Physician profile
Amit Nandi
NPI 1134196850
$2,530.47
in general payments reported to CMS, 2019-2025
16 companies · $525 in 2025
The $525 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $102 · 2021: $316 · 2022: $256 · 2023: $719 · 2024: $426 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,669.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $515.07 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $438.88 | 2022-2025 | Bexsero, Penmenvy, Pediarix |
| Corium, LLC | $432.79 | 2022-2025 | Azstarys |
| Neurelis, INC. | $241.55 | 2020-2025 | Valtoco |
| Supernus Pharmaceuticals, INC. | $239.09 | 2021-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $180.85 | 2021-2023 | Quillichew Er, Dyanavel Xr, Quillivant |
| Pfizer INC. | $102.95 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.99 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $62.62 | 2024-2025 | M-M-R II, Gardasil 9, Vaxelis |
| Noven Therapeutics, LLC | $58.75 | 2025 | Xelstrym |
| Sanofi Pasteur INC. | $57.33 | 2021-2024 | |
| Qol Medical, LLC | $34.40 | 2021 | |
| Seqirus USA INC | $31.83 | 2022-2025 | Flucelvax |
| Verrica Pharmaceuticals INC. | $24.52 | 2025 | Ycanth |
| Ars Pharmaceuticals Operations, INC. | $16.11 | 2025 | Neffy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $13.74 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Nandi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.